Geode Capital Management LLC Has $201.82 Million Position in Chemed Co. (NYSE:CHE)

Geode Capital Management LLC lifted its holdings in shares of Chemed Co. (NYSE:CHE - Free Report) by 4.9% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 335,443 shares of the company's stock after buying an additional 15,791 shares during the period. Geode Capital Management LLC owned 2.23% of Chemed worth $201,820,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently bought and sold shares of CHE. Kayne Anderson Rudnick Investment Management LLC increased its holdings in shares of Chemed by 2.6% in the second quarter. Kayne Anderson Rudnick Investment Management LLC now owns 580,316 shares of the company's stock valued at $314,868,000 after buying an additional 14,651 shares in the last quarter. William Blair Investment Management LLC raised its holdings in shares of Chemed by 2.7% during the second quarter. William Blair Investment Management LLC now owns 475,372 shares of the company's stock valued at $257,927,000 after acquiring an additional 12,705 shares during the period. State Street Corp boosted its stake in Chemed by 0.8% in the 3rd quarter. State Street Corp now owns 464,354 shares of the company's stock worth $279,063,000 after purchasing an additional 3,564 shares during the period. Impax Asset Management Group plc grew its position in Chemed by 4.7% during the 3rd quarter. Impax Asset Management Group plc now owns 332,757 shares of the company's stock worth $199,977,000 after purchasing an additional 14,814 shares in the last quarter. Finally, TD Asset Management Inc lifted its holdings in shares of Chemed by 10.9% in the second quarter. TD Asset Management Inc now owns 282,753 shares of the company's stock valued at $153,416,000 after purchasing an additional 27,800 shares in the last quarter. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities analysts have recently commented on CHE shares. Royal Bank of Canada lowered their price target on shares of Chemed from $697.00 to $633.00 and set an "outperform" rating on the stock in a report on Tuesday, November 5th. StockNews.com upgraded Chemed from a "hold" rating to a "buy" rating in a report on Saturday, November 30th.

Insider Buying and Selling at Chemed

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the firm's stock in a transaction dated Thursday, September 26th. The shares were sold at an average price of $598.81, for a total value of $1,197,620.00. Following the completion of the sale, the chief executive officer now owns 103,735 shares in the company, valued at approximately $62,117,555.35. This trade represents a 1.89 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director George J. Walsh III sold 400 shares of the stock in a transaction that occurred on Thursday, September 26th. The shares were sold at an average price of $597.47, for a total transaction of $238,988.00. Following the sale, the director now directly owns 3,046 shares in the company, valued at $1,819,893.62. This trade represents a 11.61 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 5,132 shares of company stock valued at $3,003,502 in the last 90 days. 3.32% of the stock is currently owned by company insiders.

Chemed Trading Down 1.3 %

NYSE CHE traded down $6.88 during trading on Monday, hitting $540.12. 111,335 shares of the company traded hands, compared to its average volume of 86,176. Chemed Co. has a 12 month low of $523.33 and a 12 month high of $654.62. The business has a fifty day simple moving average of $570.70 and a 200 day simple moving average of $564.96. The company has a market capitalization of $8.13 billion, a P/E ratio of 27.64, a PEG ratio of 2.32 and a beta of 0.46.

Chemed (NYSE:CHE - Get Free Report) last released its quarterly earnings results on Tuesday, October 29th. The company reported $5.64 EPS for the quarter, missing analysts' consensus estimates of $5.76 by ($0.12). The firm had revenue of $606.18 million during the quarter, compared to the consensus estimate of $612.22 million. Chemed had a net margin of 12.69% and a return on equity of 27.86%. The company's revenue for the quarter was up 7.4% compared to the same quarter last year. During the same period in the prior year, the business earned $5.32 EPS. Equities research analysts predict that Chemed Co. will post 21.43 EPS for the current fiscal year.

Chemed Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, December 6th. Investors of record on Monday, November 18th were given a $0.50 dividend. The ex-dividend date of this dividend was Monday, November 18th. This represents a $2.00 annualized dividend and a yield of 0.37%. Chemed's dividend payout ratio (DPR) is currently 10.11%.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.